Wenyi Wang

33.6k total citations · 2 hit papers
146 papers, 5.0k citations indexed

About

Wenyi Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenyi Wang has authored 146 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 33 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Wenyi Wang's work include Cancer Genomics and Diagnostics (18 papers), Head and Neck Cancer Studies (12 papers) and Cancer-related molecular mechanisms research (12 papers). Wenyi Wang is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Head and Neck Cancer Studies (12 papers) and Cancer-related molecular mechanisms research (12 papers). Wenyi Wang collaborates with scholars based in United States, China and Taiwan. Wenyi Wang's co-authors include Jin‐Ching Lin, Jian‐Sheng Jan, Rong‐San Jiang, Wen‐Miin Liang, Kuang Yu Chen, Yau‐Huei Wei, Chen‐Yi Hsu, Clarence S.M. Chan, Liton Francisco and Giovanni Parmigiani and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Wenyi Wang

133 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

2004 685 citations Wenyi Wang et al. profile →
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

2003 620 citations Wenyi Wang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenyi Wang United States	34	1.8k	1.7k	1.2k	1.1k	1.0k	146	5.0k
Sufi M. Thomas United States	43	2.7k 1.5×	2.2k 1.3×	508 0.4×	852 0.8×	435 0.4×	106	5.2k
Satoshi Fujii Japan	44	2.3k 1.3×	2.4k 1.4×	326 0.3×	1.4k 1.3×	1.2k 1.2×	271	6.7k
Muh‐Hwa Yang Taiwan	48	4.0k 2.2×	2.9k 1.7×	329 0.3×	2.2k 2.0×	852 0.8×	164	7.6k
Qin Li China	31	1.1k 0.6×	1.3k 0.8×	405 0.3×	553 0.5×	495 0.5×	154	3.9k
Katsuhiro Uzawa Japan	41	3.6k 2.0×	1.4k 0.8×	216 0.2×	1.3k 1.2×	425 0.4×	212	5.3k
Mohammad Obaidul Hoque United States	52	5.9k 3.2×	1.8k 1.0×	177 0.2×	2.0k 1.8×	1.3k 1.3×	133	8.3k
Noboru Konishi Japan	45	3.0k 1.7×	1.4k 0.8×	111 0.1×	1.2k 1.1×	883 0.9×	239	6.3k
Edgar Selzer Austria	35	1.7k 1.0×	951 0.6×	414 0.4×	525 0.5×	400 0.4×	106	3.7k
Zhen‐Yu He China	28	874 0.5×	1.2k 0.7×	182 0.2×	1.0k 1.0×	763 0.8×	180	3.3k
Eddy S. Yang United States	37	2.2k 1.2×	1.7k 1.0×	122 0.1×	624 0.6×	247 0.2×	167	4.4k

Countries citing papers authored by Wenyi Wang

Since Specialization

Citations

This map shows the geographic impact of Wenyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Wang more than expected).

Fields of papers citing papers by Wenyi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Wang. The network helps show where Wenyi Wang may publish in the future.

Co-authorship network of co-authors of Wenyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Wang. A scholar is included among the top collaborators of Wenyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Wang. Wenyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wenyi, et al.. (2026). Association of peripheral inflammatory cell counts with depression among cancer survivors: a cross-sectional study based on the NHANES dataset. Supportive Care in Cancer. 34(2). 73–73.

Guo, Shuai, et al.. (2025). A guide to transcriptomic deconvolution in cancer. Nature reviews. Cancer. 26(2). 84–103.

Zhang, Yang, et al.. (2024). Research trends of bone tumor treatment with 3D printing technology from 2013 to 2022: a bibliometric analysis. Discover Oncology. 15(1). 359–359. 2 indexed citations

Gutierrez‐Barrera, Angelica M., et al.. (2024). Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data. Journal of Clinical Oncology. 42(18). 2186–2195. 1 indexed citations

Bahrambeigi, Vahid, Jaewon J. Lee, Vittorio Branchi, et al.. (2024). Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype. Cancer Research. 84(10). 1719–1732. 6 indexed citations

Liu, Xiaoqian, Xuesen Cheng, Yujie Jiang, et al.. (2024). A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples. Genome Research. 35(1). 147–161. 1 indexed citations

Li, Fengming, et al.. (2024). Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer. Scientific Reports. 14(1). 622–622. 1 indexed citations

Wang, Wenyi, Xiaoxu Liu, Jun Dang, & Guang Li. (2023). Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis. Frontiers in Oncology. 13. 1132423–1132423. 1 indexed citations

Chachad, Dhruv, Lalit R. Patel, Rasoul Pourebrahim, et al.. (2023). Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants. Cancer Research. 83(14). 2297–2311. 6 indexed citations

10.

Čermáková, Kateřina, Ling Tao, Milan Dejmek, et al.. (2023). Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF. Nucleic Acids Research. 52(1). 4–21. 5 indexed citations

11.

Huang, Yu, et al.. (2023). Brittleness Estimation from Late Permian Mud Shale Well-Log Data at Songliao Basin Applying Rock Physical Simulation. Pure and Applied Geophysics. 180(11). 3919–3945. 1 indexed citations

12.

Shi, Yewen, Xiaoyong Ren, Shaolong Cao, et al.. (2023). TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 11(8). e006666–e006666. 16 indexed citations

13.

Wang, Jennifer, Xu Li, Maitrayee Goswami, et al.. (2022). Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precision Oncology. 6(6). e2100504–e2100504. 45 indexed citations

14.

Loh, Nellie Y., Wenyi Wang, Raymond Noordam, & Constantinos Christodoulides. (2022). Obesity, Fat Distribution and Risk of Cancer in Women and Men: A Mendelian Randomisation Study. Nutrients. 14(24). 5259–5259. 20 indexed citations

15.

Xu, Hanfei, Karen Schwander, Michael R. Brown, et al.. (2021). Lifestyle Risk Score: handling missingness of individual lifestyle components in meta-analysis of gene-by-lifestyle interactions. European Journal of Human Genetics. 29(5). 839–850. 3 indexed citations

16.

Shin, Seung Jun, Fan Gao, Jasmina Bojadzieva, et al.. (2019). Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective. Cancer Research. 80(2). 347–353. 11 indexed citations

17.

Peng, Gang, Jasmina Bojadzieva, Mandy L. Ballinger, et al.. (2017). Estimating TP53 Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO. Cancer Epidemiology Biomarkers & Prevention. 26(6). 837–844. 11 indexed citations

18.

Wang, Wenyi, et al.. (2016). Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study. PLoS ONE. 11(10). e0164019–e0164019. 8 indexed citations

19.

Wang, Wenyi, Kristin B. Niendorf, Amanda L. Blackford, et al.. (2010). Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO. Cancer Research. 70(2). 552–559. 34 indexed citations

20.

Ju, Tongzhong, Grainger S. Lanneau, Tripti Gautam, et al.. (2008). Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc. Cancer Research. 68(6). 1636–1646. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact